We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-10 of 112

Maryland Court of Appeals clarifies scope of wrongful discharge tort
  • Whiteford Taylor & Preston LLP
  • USA
  • September 26 2011

Maryland courts have long recognized a common law right of action for employees who allege that they were terminated in violation of a public policy.

In-house counsel acquitted of obstruction charges arising from dealings with federal agency
  • Kelley Drye & Warren LLP
  • USA
  • May 12 2011

On May 9, a federal judge in Baltimore acquitted a former associate general counsel of GlaxoSmithKline PLC ("GSK") of all charges of obstructing justice and lying to federal authorities in an investigation into the off-label marketing of the anti-depressant drug Wellbutrin.

Former in-house counsel with pharmaceutical company reindicted
  • Jones Day
  • USA
  • April 21 2011

On April 13, 2011, a federal grand jury in Maryland returned an indictment charging Lauren Stevens, formerly a vice president and associate general counsel for GlaxoSmithKline (GSK), with obstruction of justice and making false statements to the Food and Drug Administration (FDA) in connection with an investigation into allegations that the drug Wellbutrin had been marketed for unapproved uses.

Judge dismisses without prejudice bellwether indictment of GSK attorney
  • Faegre Baker Daniels LLP
  • USA
  • March 31 2011

As previously reported, media and legal analysts speculated that the November 8, 2010 indictment of former GlaxoSmithKline vice-president and associate general counsel Lauren Stevens would have a chilling effect on the lawyers and executives in the pharmaceutical industry.

FDA chemist charged for serial insider trading
  • Dorsey & Whitney LLP
  • USA
  • March 30 2011

FDA chemist Cheng Yi Liang was named as a defendant along with his son Andrew Liang in a criminal insider trading complaint.

Maryland insurance commissioner steps down
  • Locke Lord LLP
  • USA
  • December 21 2009

On December 16, 2009, the Maryland Insurance Administration (“MIA”) issued a media advisory announcing that Ralph S. Tyler will step down as Commissioner of the MIA effective January 8, 2010.

Rachel E. Yount
  • Arent Fox LLP